Amgen spikes interest in live virus vaccines for hard-to-treat cancers

Nat Biotechnol. 2011 Apr;29(4):295-6. doi: 10.1038/nbt0411-295.
No abstract available

Publication types

  • News

MeSH terms

  • Cancer Vaccines / immunology*
  • Cancer Vaccines / pharmacology
  • Humans
  • Oncolytic Virotherapy / methods*
  • Oncolytic Viruses / metabolism
  • Vaccines, Attenuated / immunology
  • Vaccines, Attenuated / pharmacology

Substances

  • Cancer Vaccines
  • Vaccines, Attenuated